Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates

Area of Science:

• Immunology
• Glycobiology
• Oncology

Background:

• Tumor cells express aberrant glycans called tumor-associated carbohydrate antigens (TACAs).
• TACAs are promising targets for carbohydrate-based anticancer vaccines.
• A key challenge is the weak immunogenicity of carbohydrate antigens.

Purpose of the Study:

• To design and synthesize novel N-modified S-linked STn analogues.
• To create protein conjugates using these analogues for enhanced immunogenicity.
• To evaluate the immunological properties of these novel glycoconjugates.

Main Methods:

• Synthesis of unnatural N-modified S-linked STn analogues.
• Activation of disaccharides and conjugation with keyhole limpet hemocyanin (KLH).
• Immunological evaluation in a mouse model.

Main Results:

• Successfully synthesized modified STn analogues and protein conjugates.
• The modified glycoconjugates induced IgG antibodies in mice.
• These antibodies recognized naturally occurring STn antigens.

Conclusions:

• Modified glycoconjugates show potential for overcoming the weak immunogenicity of TACAs.
• This approach aids in the discovery of effective carbohydrate-based anticancer vaccine candidates.
• Further research into these modified TACAs could advance cancer immunotherapy.